Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-124519

Chief Financial Officer acquired 294,473 shares (conversion)

  • Chief Financial Officer returned 294,473 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Bodenstedt Matthias · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-19 Conversion : show line 1 in the form +294,473 922,009 D
2025-12-19 Returned to the company : show line 2 in the form −294,473 0 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-19 Conversion : show line 3 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG −8,754 0 D
Loading xslF345X05/ownership.xml…